Pro Share Advisors LLC Seagen Inc. Transaction History

Pro Share Advisors LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$191.51 - $216.16 $5.65 Million - $6.38 Million	29,494 Added 18.46%	189,224 $40.1 Million
Q2 2023 Aug 10, 2023	SELL	$187.64 - $206.25 $1.98 Million - $2.18 Million	-10,558 Reduced 6.2%	159,730 $30.7 Million
Q1 2023 May 11, 2023	BUY	$127.59 - $203.08 $1.17 Million - $1.86 Million	9,166 Added 5.69%	170,288 $34.5 Million
Q4 2022 Feb 02, 2023	SELL	$117.37 - $139.17 $2.27 Million - $2.69 Million	-19,316 Reduced 10.71%	161,122 $20.7 Million
Q3 2022 Nov 04, 2022	SELL	$135.27 - $180.11 $3.99 Million - $5.31 Million	-29,468 Reduced 14.04%	180,438 $24.7 Million
Q2 2022 Aug 01, 2022	SELL	$108.81 - $179.33 $11.5 Million - $18.9 Million	-105,303 Reduced 33.41%	209,906 $37.1 Million
Q1 2022 May 10, 2022	SELL	$119.61 - $157.85 $3 Million - $3.96 Million	-25,093 Reduced 7.37%	315,209 $45.4 Million
Q4 2021 Feb 08, 2022	BUY	$142.57 - $190.86 $15.6 Million - $20.9 Million	109,533 Added 47.46%	340,302 $52.6 Million
Q3 2021 Nov 12, 2021	BUY	$142.45 - $169.82 $3.5 Million - $4.17 Million	24,536 Added 11.9%	230,769 $39.2 Million
Q2 2021 Aug 13, 2021	SELL	$135.08 - $161.1 $632,984 - $754,914	-4,686 Reduced 2.22%	206,233 $32.6 Million
Q1 2021 May 14, 2021	BUY	$137.51 - $190.8 $4.27 Million - $5.92 Million	31,037 Added 17.25%	210,919 $29.3 Million
Q4 2020 Feb 09, 2021	BUY	$164.63 - $211.93 $29.6 Million - $38.1 Million	179,882 New	179,882 $31.5 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.